Biochemical responses in cultured cells following exposure to 89SrCl2: Potential relevance to the mechanism of action in pain palliation

European Journal of Cancer

Volumn 37, Issue 18, 2001, Pages 2464-2469

  Davis, J ^a   Pither, R J ^a  

^a GENERAL ELECTRIC COMPANY   (United States)

Author keywords

Bone; E2; Interleukin 6; Pain palliation; Prostaglandin; Radioisotope; Radiopharmaceutical; Strontium

Indexed keywords

INTERLEUKIN 6; PROSTAGLANDIN E2; RADIOPHARMACEUTICAL AGENT; STRONTIUM CHLORIDE SR 89; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; BONE TURNOVER; CANCER CELL CULTURE; CARCINOMA CELL; CELL ACTIVITY; CELL LINE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PAIN; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIATION RESPONSE; TOXICITY; X RAY;

BONE NEOPLASMS; CELL SURVIVAL; DINOPROSTONE; DRUG EVALUATION, PRECLINICAL; HUMANS; INTERLEUKIN-6; PAIN; PALLIATIVE CARE; STRONTIUM; TUMOR CELLS, CULTURED; X-RAYS;

EID: 0035192598     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00305-7     Document Type: Article

References (27)

1. Treatment of metastatic cancer to bone
2. Sr-89: Treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone
3. Selective accumulation of strontium-89 in metastatic deposits in bone: Radio-histological correlation
4. Sr-89 therapy: Strontium kinetics in disseminated carcinoma of the prostate
5. Radionuclide-targeted therapy for the management of metastatic bone pain
6. Strontium-89 therapy: Measurement of absorbed dose to skeletal metastases
7. 2 incorporation into type I collagen during bone mineralization
8. A direct measurement of strontium-89 activity in bone metastases
9. Hemibody irradiation for metastatic bone pain in two histologically distinct groups of patients
10. IL-6 is produced by osteoblasts and induces bone resorption
11. Interleukin-6; an osteotropic factor?
12. Radiobiological studies of PC-3 and DU-145 human prostate cancer cells: X-ray sensitivity in vitro and hypoxic fractions of xenografted tumours in vivo
13. Interleukin-6 synthesis induced by prostaglandins E: Cross-talk regulation by protein kinase C
14. Dose estimation in strontium-89 radiotherapy of metastatic prostate carcinoma
15. Radiation-induced apoptosis in HL60 cells: Oxygen effect, relationship between apoptosis and loss of clonogenicity, and dependence of time to apoptosis on radiation dose
16. Radiosensitivity of human breast cancer cell lines of different hormonal responivness. Modulatory effects of oestradiol
17. Stimulation of bone resorption by various prostaglandins in organ culture
18. 2
19. Prostaglandin E2 stimulates preosteoblast replication: An autoradiographic study in cultured fetal rat calvariae
20. Induction of osteoblastic cell differentiation by forskolin. Stimulation of cyclic AMP production and alkaline phosphatase activity
21. Biosynthesis of membrane lipids
22. 2 on bone formation in cultured fetal rat calvariae: Interaction with cortisol
23. Indomethacin for prevention of heterotropic ossification- a randomized controlled study in 41 hip arthroplasties
24. Comparison of in vivo murine intestinal radiation protection by E-prostaglandins
25. 2 increses survival in mice following irradiation
26. Radiation protection in vivo by prostaglandins and related compounds of the arachidonic acid cascade
27. Parathyriod hormone (PTH) and PTH-like protein PLP stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesis